Zoeken naar een in de bibliotheek beschikbaar exemplaar
Bibliotheken met dit item worden gezocht…
Details
| Genre: | Internetbron |
|---|---|
| Soort document: | Boek, Internetbron |
| Alle auteurs / medewerkers: |
Marcia Angell |
| ISBN: | 0375508465 9780375508462 |
| OCLC-nummer: | 54035188 |
| Beschrijving: | xx, 305 p. ; 25 cm. |
| Inhoud: | Introduction : Drugs are different -- 1. The $200 billion colossus -- 2. The creation of a new drug -- 3. How much does the pharmaceutical industry really spend on R & D? -- 4. Just how innovative is this industry? -- 5. "Me-too" drugs : the main business of the pharmaceutical industry -- 6. How good are new drugs? -- 7. The hard sell : lures, bribes, and kickbacks -- 8. Marketing masquerading as education -- 9. Marketing masquerading as research -- 10. Patent games : stretching out monopolies -- 11. Buying influence : how the industry makes sure it gets its way -- 12. Is the party over? -- 13. How to save the pharmaceutical industry - and get our money's worth -- Afterword -- Acknowledgments -- Notes -- Index. |
| Verantwoordelijkheid: | Marcia Angell. |
| Meer informatie: |
Fragment:
Angell watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices.
Beoordelingen
Beoordeling toevoegen en deel uw mening met andere lezers.
U bent de eerste
Beoordeling toevoegen en deel uw mening met andere lezers.
U bent de eerste
Tags
Tags toevoegen voor "The truth about the drug companies : how they deceive us and what to do about it".
U bent de eerste.
Vergelijkbare items
Verwante onderwerpen:(17)
- Pharmaceutical industry -- United States -- Costs.
- Drugs -- Prices -- United States.
- Drugs -- Research -- United States -- Finance.
- Prescription pricing -- United States.
- Advertising -- Drugs -- United States.
- Pharmaceutical policy -- United States.
- Industrie pharmaceutique -- États-Unis -- Coût.
- Médicaments -- Prix -- États-Unis.
- Médicaments -- Recherche -- États-Unis -- Finances.
- Médicaments -- Publicité -- États-Unis.
- Médicaments -- Politique gouvernementale -- États-Unis.
- Farmaceutische industrie.
- Winst.
- Ethiek.
- Drug Industry -- economics -- United States.
- Advertising as Topic -- United States.
- Pharmaceutical Preparations -- economics -- United States.
